A LIPOSOMAL CO-DELIVERY SYSTEM FOR DOXORUBICIN AND AN ANTI-PD-L1 NANOBODY SYNERGIZES CHEMO-IMMUNOTHERAPY IN A MURINE COLON CARCINOMA MODEL. JMHSR [Internet]. 2025 Nov. 27 [cited 2026 Mar. 23];2(4). Available from: https://jmhsr.info/index.php/jmhsr/article/view/873